Diabetic nephropathy and transforming growth factor-beta: transforming our view of glomerulosclerosis and fibrosis build-up.
about
Growth hormone (GH)-dependent expression of a natural antisense transcript induces zinc finger E-box-binding homeobox 2 (ZEB2) in the glomerular podocyte: a novel action of gh with implications for the pathogenesis of diabetic nephropathyEpidemiology of diabetic retinopathy, diabetic macular edema and related vision lossDiabetic Kidney Disease: Pathophysiology and Therapeutic TargetsMini-review: emerging roles of microRNAs in the pathophysiology of renal diseasesAS101 prevents diabetic nephropathy progression and mesangial cell dysfunction: regulation of the AKT downstream pathwayGlomerular CD34 expression in short- and long-term diabetesTransforming growth factor-beta induces cellular injury in experimental diabetic neuropathyGlibenclamide induces collagen IV catabolism in high glucose-stimulated mesangial cells.Changes of transforming growth factor beta 1 in patients with type 2 diabetes and diabetic nephropathy: A PRISMA-compliant systematic review and meta-analysisKidney-targeted transplantation of mesenchymal stem cells by ultrasound-targeted microbubble destruction promotes kidney repair in diabetic nephropathy ratsCorrelation of enhanced thrombospondin-1 expression, TGF-beta signalling and proteinuria in human type-2 diabetic nephropathy.Microarray-based approach identifies microRNAs and their target functional patterns in polycystic kidney diseaseInvestigation on the effects of the atmospheric pressure plasma on wound healing in diabetic ratsPPARgamma agonists inhibit TGF-beta-PKA signaling in glomerulosclerosis.The farnesoid X receptor modulates renal lipid metabolism and diet-induced renal inflammation, fibrosis, and proteinuria.Relationships of pancreatic beta-cell function with microalbuminuria and glomerular filtration rate in middle-aged and elderly population without type 2 diabetes mellitus: a Chinese community-based analysisGene expression programs of mouse endothelial cells in kidney development and disease.Polysaccharides from Liriopes Radix ameliorate streptozotocin-induced type I diabetic nephropathy via regulating NF-κB and p38 MAPK signaling pathways.Mouse models of diabetic nephropathy.Fenugreek Prevents the Development of STZ-Induced Diabetic Nephropathy in a Rat Model of Diabetes.Antifibrotic effects of KS370G, a caffeamide derivative, in renal ischemia-reperfusion injured mice and renal tubular epithelial cells.Glycoxidised LDL induced the upregulation of Axl receptor tyrosine kinase and its ligand in mouse mesangial cells.Parallel analysis of mRNA and microRNA microarray profiles to explore functional regulatory patterns in polycystic kidney disease: using PKD/Mhm rat model.From fibrosis to sclerosis: mechanisms of glomerulosclerosis in diabetic nephropathy.Functional implications of microRNA-215 in TGF-β1-induced phenotypic transition of mesangial cells by targeting CTNNBIP1.Messenger RNA levels of podocyte-associated proteins in subjects with different degrees of glucose tolerance with or without nephropathyDistinct actions of endothelin A-selective versus combined endothelin A/B receptor antagonists in early diabetic kidney disease.Clusterin attenuates the development of renal fibrosis.The anti-inflammatory and antifibrotic effects of Coreopsis tinctoria Nutt on high-glucose-fat diet and streptozotocin-induced diabetic renal damage in rats.Early- and advanced non-enzymatic glycation in diabetic vascular complications: the search for therapeutics.Inflammatory cytokines as predictive markers for early detection and progression of diabetic nephropathyMicroRNA circuits in transforming growth factor-β actions and diabetic nephropathy.MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets.Progesterone ameliorates diabetic nephropathy in streptozotocin-induced diabetic RatsThe Expression of miR-192 and Its Significance in Diabetic Nephropathy Patients with Different Urine Albumin Creatinine Ratio.Similarities and differences between alpha-tocopherol and gamma-tocopherol in amelioration of inflammation, oxidative stress and pre-fibrosis in hyperglycemia induced acute kidney inflammation.Heterozygous knockout of transforming growth factor-β1 protects Dahl S rats against high salt-induced renal injury.Angiotensin mediates renal fibrosis in the nephropathy of glycogen storage disease type IaObesity and insulin resistance as risk factors for chronic kidney disease.Resistance to insulin and kidney disease in the cardiorenal metabolic syndrome; role for angiotensin II.
P2860
Q24634127-E403C199-B429-4453-BE8B-9D5CF0DB25F2Q26775552-E869E714-C4D2-4949-8CE4-C9DACA6284F4Q28086840-23FDDF4D-B036-497A-8B5C-1B7AAE7071F9Q28354033-82280BEB-CF5D-4137-A4F1-3BE264EB23EBQ28542507-BEF6A8A3-51A2-4FA3-995B-33FC73A00A73Q28575000-93861506-A25B-408A-B2DE-87E4F441B66CQ28575618-688A816A-869B-4197-BFEA-2B9A6853671FQ29347062-F31526B1-F7AA-4412-864D-7C51280963AEQ29994602-AD8594C5-64B1-497A-9466-0E894A221C30Q30453566-59FECFDA-7B62-4AA8-BC23-7C453AA25686Q33357230-4E280539-7C6C-49F5-A9ED-BB342AE72594Q33395144-50A7D2D0-3A05-4065-A7DD-8CBB6A13D488Q33467277-4333FC19-97C3-44D0-A4E0-DEF55930FF02Q33520918-7F0CA98A-2D31-4AD9-B743-A86A72A159ABQ33570124-6996FB32-3915-4002-8300-88628D39359FQ33649859-9BB23BD7-7E02-4B3D-9C55-98431E656FAEQ33656631-E8B48812-8D87-419C-AC24-AAF530E00790Q33696675-976CFC02-B779-4DAB-9821-4C9C97BFDAE3Q33821186-3CC6B5A5-2D01-45BA-8FA6-A172545E22B5Q33905101-9047A9AB-2ABA-4DE9-9BE5-65CD19076CA9Q33941969-3F0899D8-73CF-40CC-9AA3-2BD933B44679Q34505237-06032162-560F-4D75-AABB-2C694F971F53Q34551756-C9CF551A-23AC-4830-A1D9-6B2E17265E63Q34554570-C3295ADD-F237-48FD-8B3A-095910E859E5Q34648147-DDFC08CE-AA85-41FD-8A07-0397DB823E72Q35011234-AA628DAF-19CA-4260-80DA-71DB9911871EQ35077906-E0D2AA2B-8DAE-470F-BD25-E248C131C7D8Q35720816-06388434-E9D3-41E7-BA00-FA58F0CC2078Q35766321-4B83E90D-9783-4B07-89B4-C583CF6891D0Q35809946-D3B5CEC5-F8C0-494A-9EEE-50F2D535FE71Q36117573-0D422FC5-0DE8-4EFE-B70A-D6D9D66704F4Q36124250-09C92DED-A287-4365-9522-B79501687A06Q36166755-FE9AA23B-D44D-454E-BF2C-59AE3549217CQ36292425-25E01A78-A72C-4F54-BE87-ADE9B8F0BA39Q36530347-9703558F-E302-49DA-8D89-0830EE3D9988Q36547055-B193A856-3B94-4796-8D53-1DF2E43465D3Q36599920-82B005D2-1492-475B-8833-9C47976C46FDQ36717914-BEDBECEA-F8BD-47C7-B2FC-32973FF1F2F3Q36902752-A47F8759-2E0B-4DA5-8E92-E7CE1A452903Q37014674-7A57D432-048F-4A16-BA0C-66304C28F76F
P2860
Diabetic nephropathy and transforming growth factor-beta: transforming our view of glomerulosclerosis and fibrosis build-up.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Diabetic nephropathy and trans ...... lerosis and fibrosis build-up.
@ast
Diabetic nephropathy and trans ...... lerosis and fibrosis build-up.
@en
type
label
Diabetic nephropathy and trans ...... lerosis and fibrosis build-up.
@ast
Diabetic nephropathy and trans ...... lerosis and fibrosis build-up.
@en
prefLabel
Diabetic nephropathy and trans ...... lerosis and fibrosis build-up.
@ast
Diabetic nephropathy and trans ...... lerosis and fibrosis build-up.
@en
P2093
P1476
Diabetic nephropathy and trans ...... lerosis and fibrosis build-up.
@en
P2093
Belinda Jim
Fuad N Ziyadeh
Sheldon Chen
P304
P356
10.1053/S0270-9295(03)00132-3
P577
2003-11-01T00:00:00Z